vs

Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and SOUNDTHINKING, INC. (SSTI). Click either name above to swap in a different company.

AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $24.8M, roughly 1.8× SOUNDTHINKING, INC.). SOUNDTHINKING, INC. runs the higher net margin — -11.2% vs -19.9%, a 8.8% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 5.9%). SOUNDTHINKING, INC. produced more free cash flow last quarter ($3.7M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs -1.2%).

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

SoundThinking, Inc. is a public safety technology provider specializing in acoustic monitoring solutions, most notably gunshot detection systems. It delivers data-driven tools and analytics services to law enforcement agencies, municipal governments and public safety organizations primarily across North America, helping improve emergency response efficiency and community safety outcomes.

ABCL vs SSTI — Head-to-Head

Bigger by revenue
ABCL
ABCL
1.8× larger
ABCL
$44.9M
$24.8M
SSTI
Growing faster (revenue YoY)
ABCL
ABCL
+782.5% gap
ABCL
788.4%
5.9%
SSTI
Higher net margin
SSTI
SSTI
8.8% more per $
SSTI
-11.2%
-19.9%
ABCL
More free cash flow
SSTI
SSTI
$48.3M more FCF
SSTI
$3.7M
$-44.6M
ABCL
Faster 2-yr revenue CAGR
ABCL
ABCL
Annualised
ABCL
112.3%
-1.2%
SSTI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ABCL
ABCL
SSTI
SSTI
Revenue
$44.9M
$24.8M
Net Profit
$-8.9M
$-2.8M
Gross Margin
50.9%
Operating Margin
-63.7%
-10.2%
Net Margin
-19.9%
-11.2%
Revenue YoY
788.4%
5.9%
Net Profit YoY
73.9%
32.0%
EPS (diluted)
$-0.03
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABCL
ABCL
SSTI
SSTI
Q4 25
$44.9M
$24.8M
Q3 25
$9.0M
$25.1M
Q2 25
$17.1M
$25.9M
Q1 25
$4.2M
$28.3M
Q4 24
$5.0M
$23.4M
Q3 24
$6.5M
$26.3M
Q2 24
$7.3M
$27.0M
Q1 24
$10.0M
$25.4M
Net Profit
ABCL
ABCL
SSTI
SSTI
Q4 25
$-8.9M
$-2.8M
Q3 25
$-57.1M
$-2.0M
Q2 25
$-34.7M
$-3.1M
Q1 25
$-45.6M
$-1.5M
Q4 24
$-4.1M
Q3 24
$-51.1M
$-1.4M
Q2 24
$-36.9M
$-752.0K
Q1 24
$-40.6M
$-2.9M
Gross Margin
ABCL
ABCL
SSTI
SSTI
Q4 25
50.9%
Q3 25
54.3%
Q2 25
53.3%
Q1 25
58.5%
Q4 24
50.0%
Q3 24
58.0%
Q2 24
59.6%
Q1 24
58.6%
Operating Margin
ABCL
ABCL
SSTI
SSTI
Q4 25
-63.7%
-10.2%
Q3 25
-851.8%
-8.2%
Q2 25
-290.2%
-11.4%
Q1 25
-1479.6%
-4.2%
Q4 24
-17.7%
Q3 24
-1439.4%
-4.0%
Q2 24
-1276.2%
-0.2%
Q1 24
-551.5%
-10.3%
Net Margin
ABCL
ABCL
SSTI
SSTI
Q4 25
-19.9%
-11.2%
Q3 25
-637.8%
-8.1%
Q2 25
-203.3%
-12.1%
Q1 25
-1077.2%
-5.2%
Q4 24
-17.4%
Q3 24
-785.4%
-5.5%
Q2 24
-504.3%
-2.8%
Q1 24
-408.0%
-11.4%
EPS (diluted)
ABCL
ABCL
SSTI
SSTI
Q4 25
$-0.03
$-0.22
Q3 25
$-0.19
$-0.16
Q2 25
$-0.12
$-0.24
Q1 25
$-0.15
$-0.12
Q4 24
$-0.32
Q3 24
$-0.17
$-0.11
Q2 24
$-0.13
$-0.06
Q1 24
$-0.14
$-0.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABCL
ABCL
SSTI
SSTI
Cash + ST InvestmentsLiquidity on hand
$128.5M
$15.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$966.9M
$72.2M
Total Assets
$1.4B
$135.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABCL
ABCL
SSTI
SSTI
Q4 25
$128.5M
$15.8M
Q3 25
$83.2M
$11.8M
Q2 25
$92.4M
$8.9M
Q1 25
$159.3M
$11.7M
Q4 24
$156.3M
$13.2M
Q3 24
$126.6M
$15.3M
Q2 24
$148.3M
$9.8M
Q1 24
$123.6M
$8.5M
Stockholders' Equity
ABCL
ABCL
SSTI
SSTI
Q4 25
$966.9M
$72.2M
Q3 25
$964.0M
$73.5M
Q2 25
$1.0B
$74.5M
Q1 25
$1.0B
$73.8M
Q4 24
$1.1B
$72.4M
Q3 24
$1.1B
$73.3M
Q2 24
$1.1B
$75.6M
Q1 24
$1.1B
$74.8M
Total Assets
ABCL
ABCL
SSTI
SSTI
Q4 25
$1.4B
$135.8M
Q3 25
$1.4B
$134.4M
Q2 25
$1.4B
$134.8M
Q1 25
$1.3B
$136.3M
Q4 24
$1.4B
$136.8M
Q3 24
$1.4B
$141.7M
Q2 24
$1.4B
$145.9M
Q1 24
$1.5B
$145.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABCL
ABCL
SSTI
SSTI
Operating Cash FlowLast quarter
$-34.7M
$4.5M
Free Cash FlowOCF − Capex
$-44.6M
$3.7M
FCF MarginFCF / Revenue
-99.4%
14.9%
Capex IntensityCapex / Revenue
21.9%
3.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-174.1M
$4.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABCL
ABCL
SSTI
SSTI
Q4 25
$-34.7M
$4.5M
Q3 25
$-52.6M
$6.2M
Q2 25
$-32.4M
$-1.3M
Q1 25
$-11.6M
$-141.0K
Q4 24
$-108.6M
$-859.0K
Q3 24
$-28.9M
$13.7M
Q2 24
$-30.0M
$4.4M
Q1 24
$-41.7M
$5.0M
Free Cash Flow
ABCL
ABCL
SSTI
SSTI
Q4 25
$-44.6M
$3.7M
Q3 25
$-61.5M
$4.9M
Q2 25
$-45.8M
$-2.7M
Q1 25
$-22.2M
$-1.0M
Q4 24
$-187.0M
$-2.2M
Q3 24
$-47.4M
$12.4M
Q2 24
$-50.1M
$2.8M
Q1 24
$-65.8M
$2.8M
FCF Margin
ABCL
ABCL
SSTI
SSTI
Q4 25
-99.4%
14.9%
Q3 25
-687.0%
19.4%
Q2 25
-267.9%
-10.3%
Q1 25
-524.0%
-3.7%
Q4 24
-3702.8%
-9.5%
Q3 24
-728.4%
47.4%
Q2 24
-683.8%
10.5%
Q1 24
-661.5%
11.2%
Capex Intensity
ABCL
ABCL
SSTI
SSTI
Q4 25
21.9%
3.2%
Q3 25
99.7%
5.5%
Q2 25
78.2%
5.3%
Q1 25
251.1%
3.2%
Q4 24
1552.7%
5.8%
Q3 24
284.6%
4.7%
Q2 24
274.6%
5.9%
Q1 24
242.5%
8.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons